drugset / Trial / NCT03009422

Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.

NCT03009422 ↗

Unknown 20 enrolled Tel-Aviv Sourasky Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators will compare the common treatment for cutaneous leishmaniasis with intra-lesional Pentostam to fractional CO2 laser with topical application of Pentostam. Outcome will be final scar appearance assesd by two dermatologist and pain measurement by VAS.

Timeline

Start
2014-11
Primary completion
2017-02
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pentostam Unknown — Topical

Indications